Cargando…

Prognostic Value of Dual-Time-Point (18)F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures

This study aimed to compare the prognostic value of quantitative measures of [(18)F]-fluorodeoxyglucose positron emission tomography with integrated computed tomography (FDG-PET/CT) for the response monitoring of patients with metastatic breast cancer (MBC). In this prospective study, 22 patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naghavi-Behzad, Mohammad, Bjerg Petersen, Charlotte, Vogsen, Marianne, Braad, Poul-Erik, Grubbe Hildebrandt, Malene, Gerke, Oke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344801/ https://www.ncbi.nlm.nih.gov/pubmed/32545312 http://dx.doi.org/10.3390/diagnostics10060398

Ejemplares similares

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST
por: Vogsen, Marianne, et al.
Publicado: (2021)

Cost-effectiveness of 2-[(18)F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2023)

2-[(18)F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer
por: Vogsen, Marianne, et al.
Publicado: (2023)

Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2021)

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond
por: Hildebrandt, Malene Grubbe, et al.
Publicado: (2019)

Comparison of Image Quality and Quantification Parameters between Q.Clear and OSEM Reconstruction Methods on FDG-PET/CT Images in Patients with Metastatic Breast Cancer
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2023)

FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review
por: Helland, Fredrik, et al.
Publicado: (2019)

Benefits and harms of implementing [(18)F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study
por: Vogsen, Marianne, et al.
Publicado: (2021)

The Pattern of Metastatic Breast Cancer: A Prospective Head-to-Head Comparison of [(18)F]FDG-PET/CT and CE-CT
por: Gram-Nielsen, Rosa, et al.
Publicado: (2023)

Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer
por: Sørensen, Jonas S., et al.
Publicado: (2020)

Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy
por: Hansen, Jeanette Ansholm, et al.
Publicado: (2021)

Prevalence of focal incidental breast uptake on FDG-PET/CT and risk of malignancy: a systematic review and meta-analysis
por: Aarstad, Else Marie, et al.
Publicado: (2019)

Learning from patient involvement in a clinical study analyzing PET/CT in women with advanced breast cancer
por: Vogsen, Marianne, et al.
Publicado: (2020)

Perspective of Patients With Metastatic Breast Cancer on Electronic Access to Scan Results: Mixed Methods Study
por: Baun, Christina, et al.
Publicado: (2020)

Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study
por: Gerke, Oke, et al.
Publicado: (2017)

Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer
por: Holm, Jorun, et al.
Publicado: (2020)

2-[18F]FDG-PET/CT in Cancer of Unknown Primary Tumor—A Retrospective Register-Based Cohort Study
por: Rimer, Heidi, et al.
Publicado: (2023)

A randomised trial of [(18)F]PSMA‐1007‐PET/CT versus NaF‐PET/CT for staging primary prostate cancer: A trial protocol
por: Buch‐Olsen, Karen Middelbo, et al.
Publicado: (2023)

Atherosclerosis imaging with (18)F-sodium fluoride PET: state-of-the-art review
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2019)

Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer
por: Baun, Christina, et al.
Publicado: (2018)

A prospective study on dual time (18)F-FDG-PET/CT in high-risk prostate cancer patients
por: Mortensen, Mike Allan, et al.
Publicado: (2018)

Low-Dose Radiation to COVID-19 Patients to Ease the Disease Course and Reduce the Need of Intensive Care
por: Høilund-Carlsen, Poul Flemming, et al.
Publicado: (2020)

Atherosclerosis Imaging with (18)F-Sodium Fluoride PET
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2020)

Value assessment of artificial intelligence in medical imaging: a scoping review
por: Fasterholdt, Iben, et al.
Publicado: (2022)

Correction: Value assessment of artificial intelligence in medical imaging: a scoping review
por: Fasterholdt, Iben, et al.
Publicado: (2023)

Fusion and Healing Prediction in Posterolateral Spinal Fusion Using (18)F-Sodium Fluoride-PET/CT
por: Constantinescu, Caius M., et al.
Publicado: (2020)

(18)F-FDG PET/CT for detection of the primary tumor in adults with extracervical metastases from cancer of unknown primary: A systematic review and meta-analysis
por: Burglin, Synne Alexandra, et al.
Publicado: (2017)

Dual time point (18)F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging ((18)F-FDG PET/CT) in primary breast cancer
por: YAMAGISHI, Yoji, et al.
Publicado: (2019)

How to increase value and reduce waste in research: initial experiences of applying Lean thinking and visual management in research leadership
por: Hildebrandt, Malene Grubbe, et al.
Publicado: (2022)

Common carotid segmentation in (18)F‐sodium fluoride PET/CT scans: Head‐to‐head comparison of artificial intelligence‐based and manual method
por: Piri, Reza, et al.
Publicado: (2022)

The value of [(18)F]fluorodeoxyglucose-PET/CT in oesophageal cancer
por: Rankin, S.
Publicado: (2011)

Takayasu arteritis detected by PET/MRI with (18)F-fluorodeoxyglucose
por: Takeishi, Yasuchika, et al.
Publicado: (2018)

(18)Fluorine-fluorodeoxyglucose PET/CT Imaging in Childhood Malignancies
por: Bıçakçı, Nilüfer, et al.
Publicado: (2021)

Utility of dual time point 18 FDG PET-CT
por: De Luca, SE, et al.
Publicado: (2014)

Forced diuresis and dual-phase (18)F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancers
por: Harkirat, S, et al.
Publicado: (2010)

Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET
por: Horiguchi, Keishi, et al.
Publicado: (2017)

A prospective (18)F-fluorodeoxyglucose positron emission tomography/computed tomography study of the neurometabolic effects in cocaine use and HIV infection
por: Mamidi, Ramya S., et al.
Publicado: (2023)

Inflammatory Pseudotumor in the Mediastinum: Imaging with (18)F-Fluorodeoxyglucose PET/CT
por: Yoon, Seok-Ho, et al.
Publicado: (2013)

Cardiac imaging with (18)F-fluorodeoxyglucose PET/MRI in hypertrophic cardiomyopathy
por: Takeishi, Yasuchika, et al.
Publicado: (2016)

NaF-PET Imaging of Atherosclerosis Burden
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o2346fih7ftj35r5bdd2go7qdf